171 related articles for article (PubMed ID: 17726008)
1. MEKK4 stimulation of p38 and JNK activity is negatively regulated by GSK3beta.
Abell AN; Granger DA; Johnson GL
J Biol Chem; 2007 Oct; 282(42):30476-84. PubMed ID: 17726008
[TBL] [Abstract][Full Text] [Related]
2. MEKK4 is an effector of the embryonic TRAF4 for JNK activation.
Abell AN; Johnson GL
J Biol Chem; 2005 Oct; 280(43):35793-6. PubMed ID: 16157600
[TBL] [Abstract][Full Text] [Related]
3. Axin utilizes distinct regions for competitive MEKK1 and MEKK4 binding and JNK activation.
Luo W; Ng WW; Jin LH; Ye Z; Han J; Lin SC
J Biol Chem; 2003 Sep; 278(39):37451-8. PubMed ID: 12878610
[TBL] [Abstract][Full Text] [Related]
4. Activation of MTK1/MEKK4 by GADD45 through induced N-C dissociation and dimerization-mediated trans autophosphorylation of the MTK1 kinase domain.
Miyake Z; Takekawa M; Ge Q; Saito H
Mol Cell Biol; 2007 Apr; 27(7):2765-76. PubMed ID: 17242196
[TBL] [Abstract][Full Text] [Related]
5. CIN85 regulates the ability of MEKK4 to activate the p38 MAP kinase pathway.
Aissouni Y; Zapart G; Iovanna JL; Dikic I; Soubeyran P
Biochem Biophys Res Commun; 2005 Dec; 338(2):808-14. PubMed ID: 16256071
[TBL] [Abstract][Full Text] [Related]
6. Stress-activated kinase pathway alteration is a frequent event in bladder cancer.
Otto KB; Acharya SS; Robinson VL
Urol Oncol; 2012; 30(4):415-20. PubMed ID: 22154358
[TBL] [Abstract][Full Text] [Related]
7. The DIX domain protein coiled-coil-DIX1 inhibits c-Jun N-terminal kinase activation by Axin and dishevelled through distinct mechanisms.
Wong CK; Luo W; Deng Y; Zou H; Ye Z; Lin SC
J Biol Chem; 2004 Sep; 279(38):39366-73. PubMed ID: 15262978
[TBL] [Abstract][Full Text] [Related]
8. Ablation of MEKK4 kinase activity causes neurulation and skeletal patterning defects in the mouse embryo.
Abell AN; Rivera-Perez JA; Cuevas BD; Uhlik MT; Sather S; Johnson NL; Minton SK; Lauder JM; Winter-Vann AM; Nakamura K; Magnuson T; Vaillancourt RR; Heasley LE; Johnson GL
Mol Cell Biol; 2005 Oct; 25(20):8948-59. PubMed ID: 16199873
[TBL] [Abstract][Full Text] [Related]
9. Multiple activation mechanisms of p38alpha mitogen-activated protein kinase.
Kang YJ; Seit-Nebi A; Davis RJ; Han J
J Biol Chem; 2006 Sep; 281(36):26225-34. PubMed ID: 16849316
[TBL] [Abstract][Full Text] [Related]
10. MEKK1/MEKK4 are responsible for TRAIL-induced JNK/p38 phosphorylation.
Sun BK; Kim JH; Nguyen HN; Oh S; Kim SY; Choi S; Choi HJ; Lee YJ; Song JJ
Oncol Rep; 2011 Feb; 25(2):537-44. PubMed ID: 21152872
[TBL] [Abstract][Full Text] [Related]
11. Selective activation of tumor-suppressive MAPKP signaling pathway by triptonide effectively inhibits pancreatic cancer cell tumorigenicity and tumor growth.
Zhang B; Meng M; Xiang S; Cao Z; Xu X; Zhao Z; Zhang T; Chen B; Yang P; Li Y; Zhou Q
Biochem Pharmacol; 2019 Aug; 166():70-81. PubMed ID: 31075266
[TBL] [Abstract][Full Text] [Related]
12. RIP1-mediated AIP1 phosphorylation at a 14-3-3-binding site is critical for tumor necrosis factor-induced ASK1-JNK/p38 activation.
Zhang H; Zhang H; Lin Y; Li J; Pober JS; Min W
J Biol Chem; 2007 May; 282(20):14788-96. PubMed ID: 17389591
[TBL] [Abstract][Full Text] [Related]
13. Axin forms a complex with MEKK1 and activates c-Jun NH(2)-terminal kinase/stress-activated protein kinase through domains distinct from Wnt signaling.
Zhang Y; Neo SY; Wang X; Han J; Lin SC
J Biol Chem; 1999 Dec; 274(49):35247-54. PubMed ID: 10575011
[TBL] [Abstract][Full Text] [Related]
14. GADD45beta/GADD45gamma and MEKK4 comprise a genetic pathway mediating STAT4-independent IFNgamma production in T cells.
Chi H; Lu B; Takekawa M; Davis RJ; Flavell RA
EMBO J; 2004 Apr; 23(7):1576-86. PubMed ID: 15044949
[TBL] [Abstract][Full Text] [Related]
15. Distinct signaling properties of mitogen-activated protein kinase kinases 4 (MKK4) and 7 (MKK7) in embryonic stem cell (ESC) differentiation.
Wang J; Chen L; Ko CI; Zhang L; Puga A; Xia Y
J Biol Chem; 2012 Jan; 287(4):2787-97. PubMed ID: 22130668
[TBL] [Abstract][Full Text] [Related]
16. Trophoblast stem cell maintenance by fibroblast growth factor 4 requires MEKK4 activation of Jun N-terminal kinase.
Abell AN; Granger DA; Johnson NL; Vincent-Jordan N; Dibble CF; Johnson GL
Mol Cell Biol; 2009 May; 29(10):2748-61. PubMed ID: 19289495
[TBL] [Abstract][Full Text] [Related]
17. A non-translational role of threonyl-tRNA synthetase in regulating JNK signaling during myogenic differentiation.
Dai C; Reyes-Ordoñez A; You JS; Chen J
FASEB J; 2021 Oct; 35(10):e21948. PubMed ID: 34569098
[TBL] [Abstract][Full Text] [Related]
18. MEK kinase 3 directly activates MKK6 and MKK7, specific activators of the p38 and c-Jun NH2-terminal kinases.
Deacon K; Blank JL
J Biol Chem; 1999 Jun; 274(23):16604-10. PubMed ID: 10347227
[TBL] [Abstract][Full Text] [Related]
19. Cloning of a novel mitogen-activated protein kinase kinase kinase, MEKK4, that selectively regulates the c-Jun amino terminal kinase pathway.
Gerwins P; Blank JL; Johnson GL
J Biol Chem; 1997 Mar; 272(13):8288-95. PubMed ID: 9079650
[TBL] [Abstract][Full Text] [Related]
20. Withanolide D induces apoptosis in leukemia by targeting the activation of neutral sphingomyelinase-ceramide cascade mediated by synergistic activation of c-Jun N-terminal kinase and p38 mitogen-activated protein kinase.
Mondal S; Mandal C; Sangwan R; Chandra S; Mandal C
Mol Cancer; 2010 Sep; 9():239. PubMed ID: 20836852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
